This online information event, taking place on 07 October 2021, will focus on IMI’s impact on patient involvement. It will explore key challenges of these projects and demonstrate how IMI contributed. IMI projects are developing resources and showcasing best practices when it comes to the question of how and when best involve patients in research. Testimonials from patients, the ultimate beneficiaries of IMI’s funded research, will also be included.
More information and registration
IMI2 has just published the indicative topics and draft topic texts for the next calls.
The following topics are currently under consideration for inclusion in future IMI calls for proposals: Weiterlesen
IMI’s first scientific symposium will take place on 22 and 23 October 2018 in Brussels. This event will reflect on 10 years of activity, and present results and work carried out by IMI projects.
The scientific programme will cover four areas in four half-day sessions:
- New targets, tools and pathways
- From concept to trial
- New clinical and regulatory paradigms
- Patient engagement along the value chain
Innovative Medicines Initiative (IMI) has launched Call 13 for proposals covering diabetes, antimicrobial resistance, neurodegenerative diseases, cancer, and medicines safety during pregnancy and breastfeeding, to name just a few. The total budget of the Call is EUR 223 million, around half of which comes from the EU’s Horizon 2020 programme, and half of which comes from EFPIA companies and IMI Associated Partners.
Further Informations and the full list of topics:
The IMI2 Partnering Platform has now been updated with the future topics foreseen for the 13th IMI2 call. Weiterlesen
Every year, the IMI Stakeholder Forum gathers Innovative Medicines Initiative (IMI) stakeholders in health and medicines R&D and provides them with an opportunity to learn about and discuss IMI’s latest activities and plans.
More information on the event will be published shortly. IMI’s Stakeholder Forum is an excellent opportunity for all who are interested in IMI, would like to provide input on IMI’s activities and plans as well as to network with fellow stakeholders.